banning compounded semaglutide What possible ban means for patients Compounded' weight-loss drugs are a

The confusion between radiculopathy and sciatica causes many patients to misunderstand their condition, leading to delayed treatment and unnecessary suffering

Limbic and motor circuitry underlying footshock-induced reinstatement of cocaine-seeking behavior

Women interested in weight management should speak to their GP about NICE-approved options such as semaglutide (Wegovy) or tirzepatide (Mounjaro)

"With 7 additional phase 3 readouts expected in 2026..." -- Kenneth Custer, PhD, EVP Lilly Cardiometabolic Health TRIUMPH-1 -- Obesity -- RESULTS (May 2026) TRIUMPH-1 is the pivotal general-obesity trial that forms the basis of Lilly's weight-management regulatory submission